A K Singh Selected Research

photosan III

8/2000	Evaluation of (99m)Tc-labeled photosan-3, a hematoporphyrin derivative, as a potential radiopharmaceutical for tumor scintigraphy.
5/2000	Evaluation of (99m)Tc-labeled photosan-3, a hematoporphyrin derivative, as a potential radiopharmaceutical for tumor scintigraphy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

A K Singh Research Topics

Disease

10	Neoplasms (Cancer) 01/2022 - 05/2000
9	Infections 08/2018 - 10/2000
6	Pain (Aches) 06/2020 - 07/2006
6	Hypertension (High Blood Pressure) 01/2016 - 11/2001
6	Inflammation (Inflammations) 05/2012 - 07/2003
5	Reperfusion Injury 11/2002 - 02/2000
4	Thrombosis (Thrombus) 07/2021 - 05/2000
4	Insulin Resistance 12/2017 - 07/2011
4	Chronic Renal Insufficiency 06/2011 - 11/2001
4	Wounds and Injuries (Trauma) 07/2010 - 01/2000
4	Proteinuria 11/2006 - 04/2000
4	Ischemia 11/2002 - 02/2000
3	Lung Neoplasms (Lung Cancer) 01/2022 - 06/2001
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2017 - 07/2011
3	Obesity 12/2017 - 12/2001
3	Acute Kidney Injury (Acute Renal Failure) 01/2016 - 05/2000
3	Sepsis (Septicemia) 11/2014 - 03/2003
3	Breast Neoplasms (Breast Cancer) 12/2013 - 01/2001
3	Anemia 06/2011 - 08/2005
3	Asthma (Bronchial Asthma) 02/2011 - 08/2001
3	Cystic Fibrosis (Mucoviscidosis) 08/2008 - 02/2000
3	Hydrocephalus (Hydrocephaly) 08/2007 - 03/2003
3	Demyelinating Diseases (Demyelinating Disease) 12/2006 - 12/2000
3	Poisoning 03/2006 - 05/2000
2	Leukemia 01/2018 - 01/2017
2	Leishmaniasis 09/2017 - 08/2014
2	Type 2 Diabetes Mellitus (MODY) 02/2017 - 10/2013
2	Medulloblastoma 01/2017 - 09/2001
2	Dyslipidemias (Dyslipidemia) 09/2016 - 01/2002
2	Chronic Obstructive Pulmonary Disease (COPD) 04/2016 - 02/2001
2	Colitis 05/2014 - 01/2014
2	Autoimmune Diseases (Autoimmune Disease) 01/2014 - 01/2009
2	Anthrax 03/2013 - 10/2006
2	Fever (Fevers) 05/2012 - 03/2003
2	Glioma (Gliomas) 02/2006 - 09/2004
2	Hypotension (Low Blood Pressure) 06/2004 - 03/2003
2	AIDS-Related Complex (ARC) 06/2003 - 02/2002
2	Tetanus 12/2000 - 05/2000
2	Chronic Kidney Failure (Chronic Renal Failure) 05/2000 - 03/2000

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 01/2018 - 02/2000
7	EnzymesIBA 01/2021 - 02/2000
7	AntioxidantsIBA 01/2021 - 02/2000
6	CytokinesIBA 01/2015 - 03/2000
5	AcidsIBA 03/2021 - 03/2000
5	Pharmaceutical PreparationsIBA 04/2018 - 10/2002
5	AntibodiesIBA 04/2017 - 12/2000
5	AlbuminsIBA 06/2011 - 04/2000
4	AntigensIBA 09/2019 - 10/2006
4	DNA (Deoxyribonucleic Acid)IBA 03/2014 - 01/2001
4	Anti-Bacterial Agents (Antibiotics)IBA 07/2010 - 12/2002
3	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 07/2011
3	Insulin (Novolin)FDA Link 02/2017 - 04/2000
3	Hemoglobins (Hemoglobin)IBA 06/2011 - 08/2005
3	LigandsIBA 02/2011 - 05/2000
2	Starch (Cornstarch)IBA 01/2021 - 04/2002
2	LipidsIBA 12/2017 - 09/2016
2	VaccinesIBA 09/2017 - 01/2015
2	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2016 - 05/2000
2	Complement System Proteins (Complement)IBA 02/2016 - 03/2000
2	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2016 - 09/2000
2	Immunoglobulin M (IgM)IBA 01/2016 - 07/2015
2	ImmunosorbentsIBA 07/2015 - 01/2015
2	ElectrolytesIBA 05/2014 - 03/2004
2	ChloridesIBA 05/2014 - 02/2001
2	AnionsIBA 05/2014 - 08/2008
2	InterleukinsIBA 01/2014 - 06/2011
2	Biological Warfare AgentsIBA 03/2013 - 05/2012
2	AntidotesIBA 05/2012 - 03/2006
2	Interleukin-6 (Interleukin 6)IBA 10/2011 - 06/2011
2	ResistinIBA 10/2011 - 07/2011
2	CholesterolIBA 07/2011 - 01/2000
2	Triglycerides (Triacylglycerol)IBA 07/2011 - 01/2002
2	Interleukin-4 (Interleukin 4)IBA 02/2011 - 01/2010
2	OvalbuminIBA 01/2010 - 04/2006
2	Phosphotransferases (Kinase)IBA 02/2006 - 11/2002
2	Lovastatin (Mevacor)FDA LinkGeneric 02/2006 - 10/2001
2	LipopolysaccharidesIBA 09/2004 - 07/2003
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 06/2004 - 09/2000
2	HDL CholesterolIBA 01/2002 - 12/2001
2	Liposomes (Liposome)IBA 01/2001 - 12/2000
2	Estrogens (Estrogen)FDA Link 01/2001 - 05/2000
2	Botulinum Toxins (Botulinum Toxin)IBA 12/2000 - 05/2000
2	Messenger RNA (mRNA)IBA 12/2000 - 02/2000
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 08/2000 - 05/2000
2	RadiopharmaceuticalsIBA 08/2000 - 05/2000
2	Radioisotopes (Radionuclides)IBA 08/2000 - 05/2000
2	Hematoporphyrin DerivativeIBA 08/2000 - 05/2000
2	Photosensitizing Agents (Photosensitizers)IBA 08/2000 - 05/2000
2	photosan IIIIBA 08/2000 - 05/2000
2	Technetium (Technetium 99m)IBA 08/2000 - 05/2000
2	kutkinIBA 05/2000 - 05/2000

Therapy/Procedure

14	Therapeutics 12/2019 - 05/2000
5	Radiotherapy 01/2022 - 09/2000
3	Ventriculostomy 08/2007 - 03/2003
2	Laparoscopic Cholecystectomy 07/2020 - 07/2007
2	Length of Stay 06/2020 - 08/2001
2	Lithotripsy (Extracorporeal Shockwave Lithotripsy) 01/2020 - 07/2006
2	Drug Therapy (Chemotherapy) 01/2017 - 07/2015
2	Electrodes (Electrode) 06/2003 - 01/2001
2	Photochemotherapy (Photodynamic Therapy) 08/2000 - 05/2000